The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. 1998

M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
Harold C. Simmons Arthritis Research Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235, USA.

Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known. B27 transgenic rats develop a spontaneous disease resembling the human spondyloarthropathies that includes arthritis and colitis. To investigate whether this disease requires the binding of specific peptides to B27, we made a minigene construct in which a peptide from influenza nucleoprotein, NP383-391 (SRYWAIRTR), which binds B27 with high affinity, is targeted directly to the ER by the signal peptide of the adenovirus E3/gp19 protein. Rats transgenic for this minigene, NP1, were made and bred with B27 rats. The production of the NP383-391 peptide in B27(+)NP1(+) rats was confirmed immunologically and by mass spectrometry. The NP1 product displaced approximately 90% of the 3H-Arg-labeled endogenous peptide fraction in B27(+)NP1(+) spleen cells. Male B27(+)NP1(+) rats had a significantly reduced prevalence of arthritis, compared with B27(+)NP- males or B27(+) males with a control construct, NP2, whereas colitis was not significantly affected by the NP1 transgene. These findings support the hypothesis that B27-related arthritis requires binding of a specific peptide or set of peptides to B27, and they demonstrate a method for efficient transgenic targeting of peptides to the ER.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009698 Nucleoproteins Proteins conjugated with nucleic acids. Nucleoprotein
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females

Related Publications

M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
April 2017, Molecular & cellular proteomics : MCP,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
March 2001, European cytokine network,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
June 1980, Revue du rhumatisme et des maladies osteo-articulaires,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
January 1997, Toxicologic pathology,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
April 2000, The Journal of pharmacology and experimental therapeutics,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
October 1998, The American journal of the medical sciences,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
March 1985, Biochemistry,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
June 1983, Srpski arhiv za celokupno lekarstvo,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
April 1998, Annales de medecine interne,
M Zhou, and A Sayad, and W A Simmons, and R C Jones, and S D Maika, and N Satumtira, and M L Dorris, and S J Gaskell, and R S Bordoli, and R B Sartor, and C A Slaughter, and J A Richardson, and R E Hammer, and J D Taurog
September 1991, Nature,
Copied contents to your clipboard!